Status:

COMPLETED

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

Lead Sponsor:

Swedish Medical Center

Collaborating Sponsors:

Genzyme, a Sanofi Company

Conditions:

Renal Transplantation

Immunosuppression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study proposes to examine the effect of TMG therapy upon the cellular elements within the central (bone marrow) and peripheral (lymph node) lymphoid compartments of humans. Briefly, bone marrow a...

Detailed Description

Polyclonal anti-thymocyte globulins are used with increasing frequency to induce immunosuppression in organ transplant recipients. Induction therapy is used for the majority of persons receiving kidne...

Eligibility Criteria

Inclusion

  • All subjects age 18 years or older who qualify to receive a living (related or unrelated) kidney allograft using steroid free induction immunosuppression.
  • Single organ recipient (kidney only)
  • Subjects receiving first renal transplant
  • Women of childbearing potential should have a negative serum pregnancy test within 1 week prior to beginning study medications
  • Subjects with no prior history of immunosuppression
  • Subjects with no systemic illness (i.e. diabetes, autoimmune disease)
  • Subjects with negative serologies (Hep B, Hep C, HIV)
  • Subjects who are candidates for TMG induction
  • Subjects providing written consent
  • Subjects who are compliant and able to complete all the assessment procedures

Exclusion

  • Subjects less than 18 years of age
  • Subjects who do not meet criteria for steroid free protocol
  • Subjects who are pregnant, lactating or nursing
  • Child bearing women not willing to use a reliable form of contraception
  • Subjects with a known allergy to rabbits or rabbit products
  • Subjects receiving other medications considered to be experimental

Key Trial Info

Start Date :

July 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT00714480

Start Date

July 1 2008

End Date

December 1 2009

Last Update

August 4 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Swedish Medical Center

Seattle, Washington, United States, 98122